Huang Kelly 4
4 · OBALON THERAPEUTICS INC · Filed Sep 8, 2017
Insider Transaction Report
Form 4
Huang Kelly
DirectorPres & Chief Executive Officer
Transactions
- Award
Stock Option (Right to Buy)
[F1]2017-09-06+269,230→ 269,230 totalExercise: $9.31Exp: 2027-09-05→ Common Stock (269,230 underlying)
Footnotes (1)
- [F1]This option vests as to 25% of the total shares on September 6, 2018, then 2.083% monthly, with 100% of the total shares vested on September 6, 2021, subject to the reporting person's provision of service to the Issuer on each vesting date.
Signature
/s/ Nooshin Hussainy as attorney-in-fact for Kelly Huang|2017-09-08